Skip to main content
. 2018 Jul 1;10(1):e2018042. doi: 10.4084/MJHID.2018.042

Figure 1.

Figure 1

The 10 × 10 dot plot, showing the prevalence of β-thalassemia mutations among 1273 β-thalassemia carriers detected in the ACECR medical genetics laboratory of Mashhad, during 7 years. The ratios are as follows: IVS-I-5 (42.03%), IVS-II-1 (11.23%), codons 8/9 (4.79%), codon 44 (4.56%), codon 15 (3.53%), Los Angeles (2.91%), codon 5 (2.75%), IVS-I-110 (2.51%), −88 (2.20%), IVS-I-6 (1.81%), codon 39 (1.73%), IVS-II-745 (1.49%), −29 (1.49%), δβ (1.41%), 25bp deletion (1.41%), HbS (1.34%) and all other detected mutations consisted 12.80% of all of the reported pathogenic variants.